You are here

  • Home
  • Archive
  • Volume 2, Issue Suppl 3
  • Stable disease after high dose interleukin-2 (HD IL-2) immunotherapy: observations on long term survival and clinical benefit of additional HD IL-2

Article metrics

Article menu

Download PDFPDF

Poster Presentation
Stable disease after high dose interleukin-2 (HD IL-2) immunotherapy: observations on long term survival and clinical benefit of additional HD IL-2
Free

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2026

AbstractFullPdf
Dec 2019010
Jan 2020031
Feb 2020031
Apr 2020010
May 2020020
Jun 2020070
Jul 2020040
Sep 2020050
Nov 2020020
Dec 2020011
Jan 2021022
Feb 2021011
Mar 2021031
Apr 2021020
May 2021010
Jun 2021010
Aug 2021010
Sep 2021020
Oct 2021042
Nov 2021034
Dec 2021061
Jan 2022041
Feb 2022010
Mar 2022010
May 2022071
Jun 2022030
Jul 2022054
Aug 2022041
Sep 2022041
Oct 2022041
Nov 2022031
Dec 2022050
Jan 2023020
Feb 2023050
Apr 2023001
May 2023010
Jun 2023011
Jul 2023011
Aug 2023031
Oct 20230181
Nov 2023051
Dec 2023061
Jan 2024030
Feb 2024081
Mar 20240442
Apr 20240512
May 20240310
Jun 2024030
Jul 2024062
Aug 2024050
Sep 2024061
Oct 2024020
Nov 2024064
Dec 2024031
Jan 2025037
Feb 2025031
Mar 2025064
Apr 2025045
May 2025043
Jun 2025074
Dec 2025010
Jan 2026020
Mar 2026010
Total0223128